2000年～2003年广东省降血脂药利用分析  

Analysis of Antihyperlipidemics Used in Guangdong Province from2000 to 2003

作　　者：洪晓丹[1] 任斌[1] 黎曙霞[1] 郑志华[2] 容颖慈[1] 唐蕾[1] 

机构地区：[1]中山大学附属第一医院药剂科,广州市510080 [2]中国药学会广东分会,广州市510080

出　　处：《中国药房》2005年第7期520-522,共3页China Pharmacy

摘　　要：目的:评估广东省降血脂药应用情况及发展趋势。方法:对广东省2000年～2003年降血脂药购药金额、用药频度及日均费用进行统计、分析。结果:心血管药购药金额呈上升趋势;降血脂药从2001年起占心血管药购药金额的比例呈下降趋势;购药金额最高和用药频度最高的药品均为辛伐他汀。结论:他汀类和天然药物占广东省降血脂药市场的主导地位。OBJECTIVE:To eualuate the situation and the tondency of antihyperlipidemics used in Guangdong Province.METHODS:The sales volume,DDDs and daily expense of antihyperlipidemics in Guangdong Province from2000to2003were investigated and analyzed.RESULTS:The sales volumes of cardiovascular agents from2000to2003had been increasing.The proportion of antihyperlipidemics to cardiovascular agents in respect of sales volume assumed a decreasing tendency from2001.Simvastatin dominated over all other drugs in respect of sales volume and DDDs.CONCLUSION:HMG-CoA reductase in-hibitor and natural drugs dominate in the antihyperlipidemics market of Guangdong Province.

关 键 词：降血脂药 购药金额 用药频度 医院 用药分析 

分 类 号：R972.6[医药卫生—药品]